2m 2m 2m 2m 2m 2m 2m
PROTARA THERAPEU (TARA)
NASDAQ
$4.30-$0.04 (-0.92%)
Price as of Jun 03, 2026 5:37 PM EDT- $261.3MMarket Cap
- 32.32%1-Year Change
- BiotechnologyIndustry
PROTARA THERAPEU (TARA)
$4.30-$0.04 (-0.92%)
TARA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $4.34 | ||
Change | -$0.18 (-3.98%) | ||
Open | $4.47 | ||
High | $4.49 | ||
Low | $4.30 | ||
Previous Close | $4.52 | ||
Volume | 513,181 | ||
30-Day Average Volume | 806,093 | ||
1-Week Change | -9.58% | ||
1-Month Change | -18.42% | ||
1-Year Change | 32.32% | ||
3-Year Change | 49.66% | ||
5-Year Change | -53.83% | ||
Fundamentals | |||
Shares Outstanding | 56.2M | ||
Total Assets | $191.9M | ||
Market Cap | $261.3M | ||
Enterprise Value | $246.6M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$17.8M | ||
Free Cash Flow | -$21.3M | ||
EBIT | -$17.8M | ||
EBITDA | -$17.7M | ||
Net Working Capital | $131.1M | ||
EPS | -$0.31 | ||
Enterprise Value/EBITDA | -14 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -15 | ||
PEG | -1 | ||
Price/Free Cash Flow | -12 | ||
Price/Operating Cash Flow | -12 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue